Form 4: Adage Capital Acquires Pre-Funded Warrants in Abeona Therapeutics

Adage Capital Management, along with Robert Atchinson and Phillip Gross, report acquisition of pre-funded warrants in Abeona Therapeutics, potentially increasing their stake but limited by ownership restrictions.

Summary

• Adage Capital Management, L.P., along with Robert Atchinson and Phillip Gross, filed a Form 4 regarding transactions in Abeona Therapeutics Inc. [ABEO].
• The report indicates the acquisition of 2,948,475 pre-funded warrants on May 7, 2024, with an exercise price of $0.0001.
• These warrants are indirectly held through Adage Capital Partners, L.P. (ACP), with Adage Capital Management, L.P. (ACM) acting as the investment manager.
• The warrants are subject to a 'Blocker' provision, limiting exercise if it would result in beneficial ownership exceeding 9.99% of outstanding common stock.
• Robert Atchinson and Phillip Gross, as managing members of related entities, have disclaimed beneficial ownership except to the extent of their pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports a transaction.

Risks

• The 'Blocker' provision on the pre-funded warrants limits the ability to exercise them fully, potentially impacting the holder's ability to capitalize on stock appreciation.

Future Outlook

The holder of the pre-funded warrants may exercise them at any time on or after May 7, 2024, subject to the terms and conditions set forth in the Pre-funded Warrant, until it has been exercised in full.

Management Comments

• Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such Reporting Person's pecuniary interest in the securities, if any.

Industry Context

Form 4 filings are standard disclosures required by the SEC when significant changes in beneficial ownership occur, providing transparency to the market regarding insider activity.

Stakeholder Impact

• The acquisition of pre-funded warrants could potentially impact shareholders by increasing the number of shares outstanding upon exercise, subject to the Blocker.

Key Dates